A couple of days ago, the Supreme Court heard oral arguments on the most recent case on whether claims against prescription drug manufacturers are preempted by FDA regulations. The case is called Merck Sharp & Dohme Corp. v. Albrecht.
The SCotUS blog has a good short summary of the case here and an analysis of the oral argument here.
No comments:
Post a Comment